Share This
All > Rating(50)

高盛:上調統一 目標價 至7.3港元 評級 上調至「買入」

2024-05-10T11:47

... 該行指,看好飲料行業今年強勁的增長,將統一2024年至2026年純利預測上調26至29%,評級從「中性」上調至「買入」,目標價由5.7港元升至7.3港元。

...
 recommend this page to friend   Details 
 
 
 Related news
  華泰證券:給予銀河娛樂(00027....  2024-05-20T  
華泰證券5月18日發布公告。銀河娛樂:維持增持,目標價45.7港元,對應25年EV/EBITDA為11.5x銀河娛樂(2...
  華創證券:給予名創優品(09896....  2024-05-20T17:  
  交銀國際證券:給予京東物流(0261...  2024-05-20T17:  
  ...Securities下調 評級...  2024-05-20T  
  招銀國際:維持巨子生物「買入」 評級...  2024-05-20T10:  
招銀國際發布研究報告稱,維持巨子生物(02367)「買入」評級,繼續看好巨子生物功能性護膚品線上銷售的持續增長,預期注射...
  大行 評級 |大和:上調安踏體育 目...  2024-05-20T14:  
  大行 評級 |高盛:上調京東 目標價...  2024-05-20T14:  
  里昂:維持敏華控股(01999)「跑...  2024-05-20T13:  
  大行 評級 |交銀國際:上調京東物流...  2024-05-20T14:  
  大和:予京東物流「買入」 評級 目標...  2024-05-20T17:  
  Search   More 
 Latest News
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.